Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Donor cell leukemia with bone marrow necrosis].
Ikegawa S, Najima Y, Sano N, Horiguchi SI, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Senoo Y, Watanabe D, Yoshioka K, Watakabe K, Igarashi A, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Hishima T, Ohashi K. Ikegawa S, et al. Among authors: harada k. Rinsho Ketsueki. 2016;57(11):2334-2338. doi: 10.11406/rinketsu.57.2334. Rinsho Ketsueki. 2016. PMID: 27941282 Japanese.
Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Ikegawa S, et al. Among authors: harada k. Leuk Lymphoma. 2016;57(1):76-80. doi: 10.3109/10428194.2015.1063148. Leuk Lymphoma. 2016. PMID: 26084204
CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.
Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Hattori K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K. Ikegawa S, et al. Among authors: harada k. Leuk Lymphoma. 2016;57(6):1375-81. doi: 10.3109/10428194.2015.1099644. Epub 2015 Dec 23. Leuk Lymphoma. 2016. PMID: 26422713
[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis].
Kurosawa S, Doki N, Kaito S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Ikegawa S, Yosioka K, Watanabe D, Senoo Y, Watakabe K, Hagino T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Miyawaki S, Sakamaki H, Ohashi K. Kurosawa S, et al. Among authors: harada k. Rinsho Ketsueki. 2016 Apr;57(4):461-6. doi: 10.11406/rinketsu.57.461. Rinsho Ketsueki. 2016. PMID: 27169451 Review. Japanese.
Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease.
Harada K, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Ikegawa S, Hattori K, Igarashi A, Watakabe K, Senoo Y, Najima Y, Hagino T, Doki N, Kobayashi T, Kakihana K, Iino T, Sakamaki H, Ohashi K. Harada K, et al. Springerplus. 2016 Apr 23;5:512. doi: 10.1186/s40064-016-2161-1. eCollection 2016. Springerplus. 2016. PMID: 27186476 Free PMC article.
[Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation].
Hino Y, Doki N, Yamamoto K, Senoo Y, Sasajima S, Sakaguchi M, Hattori K, Kaito S, Kurosawa S, Harada K, Ikegawa S, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hino Y, et al. Among authors: harada k. Rinsho Ketsueki. 2016 May;57(5):608-12. doi: 10.11406/rinketsu.57.608. Rinsho Ketsueki. 2016. PMID: 27263786 Japanese.
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.
Harada K, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K. Harada K, et al. Int J Hematol. 2016 Dec;104(6):709-719. doi: 10.1007/s12185-016-2085-0. Epub 2016 Aug 26. Int J Hematol. 2016. PMID: 27565504
Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hattori K, Doki N, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hattori K, et al. Among authors: harada k. Ann Hematol. 2017 Feb;96(2):319-321. doi: 10.1007/s00277-016-2854-0. Epub 2016 Oct 21. Ann Hematol. 2017. PMID: 27766393 No abstract available.
Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
Ikegawa S, Doki N, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Ikegawa S, et al. Among authors: harada k. Pathol Oncol Res. 2017 Apr;23(2):433-437. doi: 10.1007/s12253-016-0162-6. Epub 2016 Dec 21. Pathol Oncol Res. 2017. PMID: 28004352 Free article.
[Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience].
Senoo Y, Yoshioka K, Kaito S, Kurosawa S, Harada K, Yamamoto K, Hino Y, Sakaguchi M, Ikegawa S, Watanabe D, Watakabe K, Hagino T, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Senoo Y, et al. Among authors: harada k. Rinsho Ketsueki. 2016;57(12):2481-2489. doi: 10.11406/rinketsu.57.2481. Rinsho Ketsueki. 2016. PMID: 28090014 Japanese.
4,844 results